Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy-Reference-Cited by-同舟云学术

Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy

Published:2018-11 Issue:5 Volume:200 Page:989-995
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kang Minyong¹,Park Jae Young²,Jeong Chang Wook³,Hwang Eu Chang⁴,Song Cheryn⁵,Hong Sung-Hoo⁶,Kwak Cheol³,Chung Jinsoo⁷,Sung Hyun Hwan¹,Jeon Hwang Gyun¹,Jeong Byong Chang¹³,Park Se Hoon⁸,Jeon Seong Soo¹,Lee Hyun Moo¹,Choi Han Yong⁹,Seo Seong Il¹

Affiliation:

1. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

2. Department of Urology, Korea University College of Medicine, Seoul, Republic of Korea

3. Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea

4. Department of Urology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea

5. Department of Urology, Asan Medical Center, Seoul, Republic of Korea

6. Department of Urology, Seoul St. Mary's Hospital, Seoul, Republic of Korea

7. Department of Urology, National Cancer Center, Goyang, Republic of Korea

8. Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

9. Department of Urology, Kangbuk Samsung Hospital, Seoul, Republic of Korea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference22 articles.

1. The past, present, and future in management of small renal masses;Ha;J Oncol,2015

2. Systemic therapy for metastatic renal cell carcinoma: a review and update;Logan;Rev Urol,2012

3. Targeted therapy for metastatic renal cell carcinoma;Afriansyah;Acta Med Indones,2016

4. Optimal management of metastatic renal cell carcinoma: current status;Escudier;Drugs,2013

5. Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: a two-center experience;Dong;Medicine (Baltimore),2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability of ChatGPT to provide medical information for patients with kidney cancer;Scientific Reports;2024-01-17

2. The Impact of COVID-19 on New Kidney Cancer Diagnosis: Stage and Treatment in Northern Italy;International Journal of Environmental Research and Public Health;2023-03-08

3. Instantaneous death risk, conditional survival and optimal surgery timing in cervical fracture patients with ankylosing spondylitis: A national multicentre retrospective study;Frontiers in Immunology;2022-09-15

4. Trends in Incidence and Mortality of Kidney Cancer in a Northern Italian Province: An Update to 2020;Biology;2022-07-13

5. Process Mining the Performance of a Real-Time Healthcare 4.0 Systems Using Conditional Survival Models;Algorithms;2022-06-07